Rafferty Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.42M | Sell |
24,533
-5,369
| -18% | -$1.62M | 0.02% | 327 |
|
|
2025
Q1 | $9.9M | Sell |
29,902
-3,221
| -10% | -$1.07M | 0.04% | 263 |
|
|
2024
Q4 | $10.2M | Sell |
33,123
-11,501
| -26% | -$3.55M | 0.04% | 280 |
|
|
2024
Q3 | $9.47M | Buy |
44,624
+8,206
| +23% | +$1.74M | 0.03% | 291 |
|
|
2024
Q2 | $10.2M | Buy |
36,418
+501
| +1% | +$140K | 0.04% | 280 |
|
|
2024
Q1 | $9.59M | Sell |
35,917
-7,182
| -17% | -$1.92M | 0.04% | 276 |
|
|
2023
Q4 | $9.97M | Sell |
43,099
-2,224
| -5% | -$515K | 0.04% | 279 |
|
|
2023
Q3 | $6.62M | Buy |
45,323
+14,067
| +45% | +$2.05M | 0.04% | 333 |
|
|
2023
Q2 | $7.22M | Buy |
31,256
+3,121
| +11% | +$721K | 0.04% | 329 |
|
|
2023
Q1 | $6.82M | Sell |
28,135
-77,255
| -73% | -$18.7M | 0.05% | 301 |
|
|
2022
Q4 | $30.6M | Buy |
105,390
+39,469
| +60% | +$11.5M | 0.26% | 66 |
|
|
2022
Q3 | $4.28M | Buy |
65,921
+34,761
| +112% | +$2.26M | 0.05% | 362 |
|
|
2022
Q2 | $2.23M | Sell |
31,160
-15,127
| -33% | -$1.08M | 0.02% | 439 |
|
|
2022
Q1 | $4.54M | Buy |
46,287
+9,740
| +27% | +$956K | 0.03% | 411 |
|
|
2021
Q4 | $3.1M | Buy |
36,547
+5,091
| +16% | +$431K | 0.02% | 528 |
|
|
2021
Q3 | $2.51M | Buy |
31,456
+7,291
| +30% | +$582K | 0.02% | 563 |
|
|
2021
Q2 | $2.35M | Sell |
24,165
-4,110
| -15% | -$400K | 0.01% | 640 |
|
|
2021
Q1 | $3.31M | Buy |
28,275
+21,301
| +305% | +$2.49M | 0.02% | 425 |
|
|
2020
Q4 | $775K | Sell |
6,974
-3,532
| -34% | -$393K | 0.01% | 580 |
|
|
2020
Q3 | $1.25M | Buy |
10,506
+2,903
| +38% | +$345K | 0.02% | 544 |
|
|
2020
Q2 | $861K | Buy |
+7,603
| New | +$861K | 0.01% | 586 |
|
|
2020
Q1 | – | Sell |
-15,679
| Closed | -$1.43M | – | 728 |
|
|
2019
Q4 | $1.43M | Sell |
15,679
-18,551
| -54% | -$1.69M | 0.02% | 468 |
|
|
2019
Q3 | $2.95M | Sell |
34,230
-4,989
| -13% | -$430K | 0.05% | 233 |
|
|
2019
Q2 | $4.11M | Buy |
39,219
+7,708
| +24% | +$808K | 0.07% | 204 |
|
|
2019
Q1 | $3.95M | Buy |
+31,511
| New | +$3.95M | 0.06% | 172 |
|